Exploring the Influence of Obesity and CYP2 C19 Genotype on Lansoprazole Pharmacokinetics in Pediatric Patients: A Population Modeling Approach is a research paper published in Clinical Pharmacokinetics (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: K23 DK115827
National Center for Advancing Translational Sciences
Grant: KL2 TR002367
National Institute of Child Health and Human Development
Grant: R01HD096435
National Institute of Child Health and Human Development
Grant: R01HD102949
National Institute of Child Health and Human Development
Grant: R01HD113201
National Institute of Child Health and Human Development
Grant: HHSN275201000003I
NIGMS NIH HHS
Grant: T32 GM086330
National Institutes of Health
Grant: 5K23DK115827-02
Effect of Obesity on Pantoprazole Pharmacokinetics and Pharmacodynamics in Children
National Institutes of Health
Grant: 3KL2TR002367-08S1
Institutional Career Development Core
National Institutes of Health
Grant: 5R01HD102949-05
Application of Physiologically-Based Pharmacokinetic Modeling to Characterize Drug-Drug Interactions in Infants
National Institutes of Health
Grant: 5T32GM086330-08
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
National Institutes of Health
Grant: 1R01HD096435-01
Physiologically-Based Pharmacokinetic Modeling to Guide Drug Dosing in Children with Obesity
National Institutes of Health
Grant: 1R01HD113201-01
PRISM
FWCI
0.88
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals